Alchemy Invest CP 1 (ALCYF) Financials
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 27, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ALCYF SEC filings page.
This page shows Alchemy Invest CP 1 (ALCYF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.
The latest balance sheet is heavily liability-funded, while reported earnings have not translated into operating cash.
FY2024 earnings quality was weak: net income of$4.2M coincided with operating cash flow of-$658.6K . By FY2025, both turned negative, with a net loss of$1.1M and operating cash flow of-$1.3M , showing that the earlier profits were not accompanied by cash generation.
Liabilities reached
Current assets of
Financial Health Signals
We do not publish a peer-relative financial health score for Alchemy Invest CP 1, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Alchemy Invest CP 1 passes 0 of 5 computable financial strength tests (4 of the nine could not be computed from available data). No profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
Alchemy Invest CP 1 reported an operating loss of $1.4M against $134K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Alchemy Invest CP 1 reported a net loss of $308K in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q2 2026.
Not reported for Q2 2026.
Not reported for Q2 2026.
Cash & Balance Sheet
Alchemy Invest CP 1 held $19K in cash as of Q2 2026; no long-term debt figure is on record for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
None of these metrics is reported for Q2 2026.
Capital Allocation
None of these metrics is reported for Q2 2026.
ALCYF Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'25Filing | Q2'2510-Q | Q1'2510-Q | Q4'24Filing | Q3'24Filing |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -$335Kn/m | -$363Kn/m | -$279Kn/m | -$428Kn/m | -$321Kn/m | -$401Kn/m | -$591Kn/m | -$158Kn/m |
| Interest Expense | $53K+88.5% | $47K+68.0% | N/A | $35K | $28K | $28K | N/A | N/A |
| Income Tax | N/A | $0n/m | N/A | N/A | N/A | $0n/m | N/A | N/A |
| Net Income | -$308Kn/m | -$332Kn/m | -$235K-467.0% | -$342K-123.5% | -$220K-116.8% | -$301K-121.3% | $64K-95.3% | $1.5M+6.9% |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, EBITDA, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
ALCYF Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'25Filing | Q2'2510-Q | Q1'2510-Q | Q4'24Filing | Q3'24Filing |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.2M-26.5% | $9.1M-26.9% | $8.9M-26.5% | $9.0M-92.8% | $12.5M-90.0% | $12.5M-89.8% | $12.1M-90.0% | $125.9M+5.1% |
| Current Assets | $85K-66.2% | $175K-61.9% | $79K-67.9% | $361K-22.3% | $251K-67.1% | $459K+24.3% | $247K-50.0% | $465K-26.2% |
| Cash & Equivalents | $19K-88.2% | $86K-75.5% | $55K-69.6% | $319K-6.0% | $161K-71.8% | $352K+172.4% | $181K-41.5% | $340K-19.9% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Liabilities | $18.6M-7.3% | $18.1M-7.8% | $17.4M-6.8% | $17.1M-87.0% | $20.1M-84.6% | $19.6M-84.7% | $18.7M-85.3% | $131.9M+5.5% |
| Current Liabilities | $4.4M+61.4% | $4.1M+61.6% | $3.5M+92.0% | $3.4M+154.1% | $2.8M+85.5% | $2.5M+204.2% | $1.8M+118.6% | $1.3M+68.9% |
| Non-Current Liabilities | $14.2M-18.2% | $14.0M-18.0% | $13.9M-17.5% | $13.7M-89.5% | $17.3M-86.6% | $17.1M-86.6% | $16.8M-86.6% | $130.5M+5.1% |
| Total Equity | -$9.4Mn/m | -$9.0Mn/m | -$8.5Mn/m | -$8.1Mn/m | -$7.6Mn/m | -$7.1Mn/m | -$6.6Mn/m | -$6.0Mn/m |
| Retained Earnings | -$9.4Mn/m | -$9.0Mn/m | -$8.5Mn/m | -$8.1Mn/m | -$7.6Mn/m | -$7.1Mn/m | -$6.6Mn/m | -$6.0Mn/m |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
ALCYF Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'25Filing | Q2'2510-Q | Q1'2510-Q | Q4'24Filing | Q3'24Filing |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$187Kn/m | -$192Kn/m | -$264Kn/m | -$572Kn/m | -$101Kn/m | -$369Kn/m | -$158Kn/m | -$233Kn/m |
| Investing Cash Flow | -$66Kn/m | -$66Kn/m | N/A | N/A | -$90K | -$60K | N/A | N/A |
| Financing Cash Flow | $186Kn/m | $290K-51.7% | $3.8M | -$3.2Mn/m | $0 | $600K | N/A | $0n/m |
| Share Buybacks | N/A | N/A | $0 | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid.
ALCYF Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Liabilities-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$8.5M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.02), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Alchemy Invest CP 1 ALCYF | FY2025 | N/A | -$1.1M | N/A | $50.2M | — |
| theglobe.com inc TGLO | FY2025 | $0 | -$226K | N/A | $58.2M | — |
| Chain Bridge I A CBRRF | FY2025 | N/A | -$1.3M | N/A | $63.9M | — |
| Israel Acq Corp A ISRLF | FY2025 | N/A | -$510K | N/A | $75.7M | — |
| Intl Media Acq Corp A IMAQ | FY2026 | N/A | -$345K | N/A | $71.8M | — |
| Piermont Valley Acq A CMCAF | FY2026 | N/A | -$1.7M | N/A | $77.4M | — |
Where Alchemy Invest CP 1 Ranks
Frequently Asked Questions
No, Alchemy Invest CP 1 (ALCYF) reported a net loss of $1.2M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net loss of $1.1M.
Alchemy Invest CP 1 (ALCYF) recorded an outflow of $1.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
Alchemy Invest CP 1 (ALCYF) had $8.9M in total assets as of fiscal year 2025, including both current and long-term assets.
Alchemy Invest CP 1 (ALCYF) had a current ratio of 0.02 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
Alchemy Invest CP 1 (ALCYF) had a return on assets of -12.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Alchemy Invest CP 1 (ALCYF) has negative shareholder equity of -$8.5M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Alchemy Invest CP 1 (ALCYF) has a Piotroski F-Score of 0 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Alchemy Invest CP 1 (ALCYF) reported an operating loss of $1.4M against $134K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.